Alto Neuroscience Inc.
ANRO | NYSE
$30.42
-$0.21 (-0.69%)
Sep 22, 2026, 1:18 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 184K | 284K | 100K | 270K | 270K | 170K | 267K | 189K | 189K | 289K | 278K | 283K | 283K | 183K | 97K |
Gross Profit | -184K | -284K | -100K | -270K | -270K | -170K | -267K | -189K | -189K | -289K | -278K | -283K | -283K | -183K | -97K |
Operating Income | 44.46M | 54.9M | 66.36M | -66.31M | -70.24M | -69.9M | -68.61M | -63.38M | -54.21M | -44.99M | -37.81M | -34.1M | -24.39M | -15.26M | -8.06M |
Interest Income | 6.77M | 6.34M | 6.6M | 7.18M | 8.15M | 9.12M | 8.85M | 7.45M | 5.67M | 3.68M | 2.35M | 1.72M | 1.01M | 342K | 112K |
Pretax Income | -84.24M | -74.31M | -63.24M | -62.26M | -64.86M | -63.18M | -61.43M | -57.45M | -49.81M | -42.44M | -36.31M | -32.74M | -23.6M | -14.94M | -7.65M |
Net Income | -84.24M | -74.31M | -63.24M | -62.26M | -64.86M | -63.18M | -61.43M | -57.45M | -49.81M | -42.44M | -36.31M | -32.74M | -23.6M | -14.94M | -7.65M |
Selling & General & Admin | 23.35M | 21.89M | 20.75M | 21.71M | 23.11M | 22.71M | 21.35M | 17.35M | 13.27M | 10.07M | 7.24M | 6.85M | 5.1M | 3.15M | 1.64M |
Research & Development | 64.92M | 55.94M | 45.62M | 44.42M | 46.96M | 47.02M | 47M | 45.84M | 40.75M | 34.63M | 30.29M | 26.97M | 19.01M | 11.93M | 6.32M |
Other Expenses | -132.91M | -133.01M | -132.83M | -100K | -100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | -44.64M | -55.19M | -66.46M | 66.04M | 69.97M | 69.73M | 68.34M | 63.19M | 54.02M | 44.71M | 37.53M | 33.82M | 24.1M | 15.08M | 7.96M |
Interest Expense | 2.26M | 2.42M | 2.47M | 2.23M | 1.93M | 1.63M | 1.38M | 1.4M | 1.41M | 1.39M | 1.37M | 1.01M | 651K | 324K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -97K | -97K | -97K | -197K | -186K | -283K | -283K | -183K | -97K |
Cost & Expenses | -44.46M | -54.9M | -66.36M | 66.31M | 70.24M | 69.9M | 68.61M | 63.38M | 54.21M | 44.99M | 37.81M | 34.1M | 24.39M | 15.26M | 8.06M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 42.81M | 32.89M | 31.92M | 27.1M | 27.07M | 27.05M | 26.99M | 26.96M | 26.95M | 26.88M | 26.88M | 26.88M | 26.88M | 26.88M | 25.57M |
Shares Outstanding (Diluted) | 42.81M | 32.89M | 31.92M | 27.1M | 27.07M | 27.05M | 26.99M | 26.96M | 26.95M | 26.88M | 26.88M | 26.88M | 26.88M | 26.88M | 25.57M |
EPS (Basic) | -2.48 | -2.48 | -2.24 | -2.29 | -2.39 | -2.33 | -2.27 | -2.13 | -1.85 | -1.58 | -1.35 | -1.23 | -0.89 | -0.57 | -0.30 |
EPS (Diluted) | -2.48 | -2.48 | -2.24 | -2.29 | -2.39 | -2.33 | -2.27 | -2.13 | -1.85 | -1.58 | -1.35 | -1.23 | -0.89 | -0.57 | -0.30 |
EBITDA | -81.47M | -71.29M | -60.18M | -59.43M | -62.37M | -60.98M | -59.55M | -55.63M | -48.03M | -40.69M | -34.59M | -31.38M | -22.67M | -14.43M | -7.56M |
EBIT | -81.98M | -71.89M | -60.77M | -60.03M | -62.93M | -61.56M | -60.06M | -56.05M | -48.39M | -41.05M | -34.94M | -31.73M | -22.95M | -14.61M | -7.65M |
Depreciation & Amortization | 505K | 605K | 592K | 605K | 563K | 576K | 502K | 424K | 365K | 352K | 341K | 346K | 283K | 183K | 97K |
Add to Watchlist
Select watchlists to add or remove ANRO